Skip to main content
Erschienen in: Clinical Oral Investigations 5/2017

22.10.2016 | Original Article

A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians

verfasst von: Sung Ok Hong, Chae-Yoon Lee, Junho Jung, Deog-Yoon Kim, Christian Walter, Yong-Dae Kwon

Erschienen in: Clinical Oral Investigations | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of this study were to find the annual case trend of inflammatory jawbone diseases and to investigate the impact of medication-related osteonecrosis of the jaws (MRONJ).

Material and methods

A retrospective study of 372 patients diagnosed with inflammatory jawbone condition except for alveolar osteitis from 2007 to 2015 was initiated. History taking and investigation of etiologic factors MRONJ, osteoradionecrosis (ORN), odontogenic infection, foreign body, and trauma were investigated. A separate analysis showed the number of MRONJ cases in two age groups (under 70 years; 70 years and over) and serum C-terminal peptide (s-CTX) values that were found.

Results

The results showed that the number of MRONJ cases was significantly larger in the older age group (p < 0.05). Regarding gender and sites of lesions, MRONJ was significantly frequent in the female and the mandible (p < 0.05). The R 2 values for the regression analysis for MRONJ (R 2 = 0.9234) and odontogenic etiology (R 2 = 0.0427) signified linear increase in the number of MRONJ cases, whereas bone lesions due to traditional odontogenic etiology stayed stationary.

Conclusion

The number of MRONJ has escalated, and most of the patients are elderly people. The current trend of inflammatory conditions of the jaw may have changed since the advent of MRONJ.

Clinical relevance

Long-term bisphosphonate therapy became a major risk factor for the osteomyelitis and osteonecrosis of the jaws. Thorough medical history, taking would be essential and communication with prescribing physicians should be emphasized during the dental treatment planning.
Literatur
1.
Zurück zum Zitat Baltensperger MM, Eyrich GK (2009) Osteomyelitis of the jaws. Springer, Berlin HeidelbergCrossRef Baltensperger MM, Eyrich GK (2009) Osteomyelitis of the jaws. Springer, Berlin HeidelbergCrossRef
3.
Zurück zum Zitat Administration USFD (2006) FDA approves new treatment for gastrointestinal and kidney cancer. Jan 26 ed Administration USFD (2006) FDA approves new treatment for gastrointestinal and kidney cancer. Jan 26 ed
9.
Zurück zum Zitat Salort-Llorca C, Minguez-Serra MP, Silvestre-Donat FJ (2011) Maxillary osteonecrosis associated to antiangiogenic drugs. Med Oral, Patologia Oral y Cirugia Bucal 16(2):e137–e138CrossRef Salort-Llorca C, Minguez-Serra MP, Silvestre-Donat FJ (2011) Maxillary osteonecrosis associated to antiangiogenic drugs. Med Oral, Patologia Oral y Cirugia Bucal 16(2):e137–e138CrossRef
11.
Zurück zum Zitat Marx R (2011) Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. Quintessence, Hanover Park, Il Marx R (2011) Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. Quintessence, Hanover Park, Il
12.
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381 Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381
13.
Zurück zum Zitat Kim JW, Jeon YJ, Baek DH et al (2014) Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int 25(4):1313–1319. doi:10.1007/s00198-013-2595-z CrossRefPubMed Kim JW, Jeon YJ, Baek DH et al (2014) Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int 25(4):1313–1319. doi:10.​1007/​s00198-013-2595-z CrossRefPubMed
17.
Zurück zum Zitat Sedghizadeh PP, Stanley K, Caligiuri M et al (2009) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw. J Am Dent Assoc 140(1):61–66CrossRefPubMed Sedghizadeh PP, Stanley K, Caligiuri M et al (2009) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw. J Am Dent Assoc 140(1):61–66CrossRefPubMed
18.
Zurück zum Zitat Sumi E, Yamazaki T, Tanaka S et al (2014) The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study. Pharmacoepidemiol Drug Saf 23(4):398–405CrossRefPubMedPubMedCentral Sumi E, Yamazaki T, Tanaka S et al (2014) The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study. Pharmacoepidemiol Drug Saf 23(4):398–405CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 20(1):117–120. doi:10.1093/annonc/mdn554 CrossRef Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 20(1):117–120. doi:10.​1093/​annonc/​mdn554 CrossRef
20.
Zurück zum Zitat Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 23(1):193–200. doi:10.1093/annonc/mdr039 CrossRef Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 23(1):193–200. doi:10.​1093/​annonc/​mdr039 CrossRef
21.
Zurück zum Zitat Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 72(10):1938–1956. doi:10.1016/j.joms.2014.04.031 CrossRef Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 72(10):1938–1956. doi:10.​1016/​j.​joms.​2014.​04.​031 CrossRef
23.
Zurück zum Zitat Ripamonti CI, Maniezzo M, Campa T et al (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 20(1):137–145. doi:10.1093/annonc/mdn526 CrossRef Ripamonti CI, Maniezzo M, Campa T et al (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol: Off J Eur Soc Med Oncol/ ESMO 20(1):137–145. doi:10.​1093/​annonc/​mdn526 CrossRef
24.
Zurück zum Zitat Montefusco V, Gay F, Spina F et al (2008) Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leukemia Lymphoma 49(11):2156–2162. doi:10.1080/10428190802483778 CrossRefPubMed Montefusco V, Gay F, Spina F et al (2008) Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leukemia Lymphoma 49(11):2156–2162. doi:10.​1080/​1042819080248377​8 CrossRefPubMed
26.
Zurück zum Zitat Kostoff MD, Saseen JJ, Borgelt LM (2014) Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy. Int J Women’s Health 6:423 Kostoff MD, Saseen JJ, Borgelt LM (2014) Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy. Int J Women’s Health 6:423
27.
Zurück zum Zitat Ziebart T, Ziebart J, Gauss L et al (2013) Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy. Biomedical Rep 1(5):719–722. doi:10.3892/br.2013.145 Ziebart T, Ziebart J, Gauss L et al (2013) Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy. Biomedical Rep 1(5):719–722. doi:10.​3892/​br.​2013.​145
28.
Zurück zum Zitat Kwon Y-D, Lee D-W, Choi B-J et al (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23(11):2721–2725CrossRefPubMed Kwon Y-D, Lee D-W, Choi B-J et al (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23(11):2721–2725CrossRefPubMed
29.
Zurück zum Zitat Lau AN, Adachi JD (2009) Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 36(8):1835–1837CrossRefPubMed Lau AN, Adachi JD (2009) Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 36(8):1835–1837CrossRefPubMed
30.
Zurück zum Zitat Lee JJ, Cheng SJ, Jeng JH et al (2011) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366–1371CrossRefPubMed Lee JJ, Cheng SJ, Jeng JH et al (2011) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366–1371CrossRefPubMed
31.
Zurück zum Zitat Altay MA, Tasar F, Tosun E et al (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg. doi:10.1089/pho.2014.3742 PubMed Altay MA, Tasar F, Tosun E et al (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg. doi:10.​1089/​pho.​2014.​3742 PubMed
32.
Zurück zum Zitat Pabst AM, Kruger M, Ziebart T et al (2015) Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro. Clin Oral Investig 19(7):1625–1633. doi:10.1007/s00784-014-1394-z CrossRefPubMed Pabst AM, Kruger M, Ziebart T et al (2015) Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro. Clin Oral Investig 19(7):1625–1633. doi:10.​1007/​s00784-014-1394-z CrossRefPubMed
33.
Zurück zum Zitat Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410CrossRefPubMed Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410CrossRefPubMed
34.
Zurück zum Zitat Kwon YD, Ohe JY, Kim DY et al (2011) Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 22(1):100–105CrossRefPubMed Kwon YD, Ohe JY, Kim DY et al (2011) Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 22(1):100–105CrossRefPubMed
35.
Zurück zum Zitat Thumbigere-Math V, Sabino MAC, Gopalakrishnan R et al (2009) Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67(9):1904–1913CrossRefPubMed Thumbigere-Math V, Sabino MAC, Gopalakrishnan R et al (2009) Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67(9):1904–1913CrossRefPubMed
Metadaten
Titel
A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians
verfasst von
Sung Ok Hong
Chae-Yoon Lee
Junho Jung
Deog-Yoon Kim
Christian Walter
Yong-Dae Kwon
Publikationsdatum
22.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 5/2017
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-016-1973-2

Weitere Artikel der Ausgabe 5/2017

Clinical Oral Investigations 5/2017 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.